Journal of Biological Engineering最新文献

筛选
英文 中文
From polyclonal to monoclonal: de novo sequencing of goat antibodies for a standardized ApoA-I immunoturbidimetric assay. 从多克隆到单克隆:山羊抗体的标准化ApoA-I免疫比浊测定从头测序。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-05-12 DOI: 10.1186/s13036-026-00697-y
Lulai Xu, Qitao Song, Ming Zhu, Wei Zhao, Qiang Li, Sai Li, Bohong Li, Linzhu Li, Bin Ma, Zhengzhong Song, Xin Yang, Yun Xie, Weijing Yi, Jing Wang
{"title":"From polyclonal to monoclonal: de novo sequencing of goat antibodies for a standardized ApoA-I immunoturbidimetric assay.","authors":"Lulai Xu, Qitao Song, Ming Zhu, Wei Zhao, Qiang Li, Sai Li, Bohong Li, Linzhu Li, Bin Ma, Zhengzhong Song, Xin Yang, Yun Xie, Weijing Yi, Jing Wang","doi":"10.1186/s13036-026-00697-y","DOIUrl":"10.1186/s13036-026-00697-y","url":null,"abstract":"<p><p>Antibodies serve as essential recognition elements in in vitro diagnostics (IVD), yet reliance on polyclonal antibodies (pAbs) introduces significant challenges related to batch-to-batch consistency. To address this, we employed a de novo sequencing platform, which identified 15 candidate monoclonal antibody (mAb) sequences. From these, four distinct mAb mixtures were formulated and evaluated. Using an immunoturbidimetric assay to quantify apolipoprotein A-I (ApoA-I) in 105 human serum samples, the performance of these mixtures was compared to that of a conventional pAb reagent. The four-mAb mixture demonstrated excellent correlation with the pAb assay (Passing-Bablok: y = 1.0536x-0.0748 g/L; r<sup>2</sup> = 0.994). This optimized cocktail successfully replaced the pAb reagent, matching or exceeding its performance in key analytical parameters including linearity, sensitivity, and precision. Our work thus establishes a practical pathway for converting heterogeneous pAbs into defined, recombinant antibody reagents suitable for standardized IVD applications.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13335323/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147929788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A pH-responsive ZnO2@ZIF-8/TCPP nanoplatform with self-supplied oxygen for hypoxia-relieved photodynamic therapy. ph响应ZnO2@ZIF-8/TCPP纳米平台与自供氧用于缺氧缓解光动力治疗。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-05-11 DOI: 10.1186/s13036-026-00695-0
Gaobing Ye, Jing Liu, Yu Jin, Renren Hu, Tianli Tian, Peilei Chen
{"title":"A pH-responsive ZnO<sub>2</sub>@ZIF-8/TCPP nanoplatform with self-supplied oxygen for hypoxia-relieved photodynamic therapy.","authors":"Gaobing Ye, Jing Liu, Yu Jin, Renren Hu, Tianli Tian, Peilei Chen","doi":"10.1186/s13036-026-00695-0","DOIUrl":"10.1186/s13036-026-00695-0","url":null,"abstract":"<p><p>Tumor hypoxia limits type-II photodynamic therapy (PDT) by restricting oxygen-dependent singlet oxygen production during irradiation. Here, we developed a pH-responsive ZnO<sub>2</sub>@ZIF-8/TCPP nanoplatform (PZZT) that integrates an acid-activated oxygen-generating core (ZnO<sub>2</sub>), a ZIF-8 gatekeeper shell, and the photosensitizer TCPP, aiming to enhance PDT under hypoxic conditions. Under mildly acidic conditions, PZZT showed improved oxygen generation and enhanced DPBF consumption upon 660 nm irradiation, indicating elevated ¹O₂ production. In 4T1 cells, PZZT + laser induced stronger intracellular ROS signals and greater phototoxicity than free TCPP or control formulations. In 4T1 tumor-bearing mice, PZZT + laser achieved the most significant tumor growth inhibition without obvious systemic toxicity. Overall, PZZT provides a practical pH-activated self-oxygen-supplying strategy to improve PDT efficacy.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13220614/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147874111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catalytic nanotherapeutics with cancer cell membrane and chitosan-coated Cu/Pt nanoparticles for gastric cancer precision therapy. 肿瘤细胞膜和壳聚糖包覆纳米Cu/Pt用于胃癌精准治疗的催化纳米疗法。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-05-09 DOI: 10.1186/s13036-026-00676-3
Wanhong Zhang, Yuchao Ma, Linjie Li, Yiyu Shi
{"title":"Catalytic nanotherapeutics with cancer cell membrane and chitosan-coated Cu/Pt nanoparticles for gastric cancer precision therapy.","authors":"Wanhong Zhang, Yuchao Ma, Linjie Li, Yiyu Shi","doi":"10.1186/s13036-026-00676-3","DOIUrl":"10.1186/s13036-026-00676-3","url":null,"abstract":"<p><p>Gastric cancer remains a major global health challenge, underscoring the need for highly effective and precisely targeted therapies. This study presents a novel biomimetic nanoplatform comprising cancer cell membrane-coated chitosan-stabilized Cu/Pt nanoparticles (CCM@Ch-Cu/PtNPs), designed to enhance tumor specificity and therapeutic efficacy. We characterized the nanocomposite using X-ray diffraction (XRD), X-ray absorption spectroscopy (XAS), and transmission electron microscopy (TEM), confirming its bimetallic architecture featuring Cu-rich and Pt-rich surface domains. In vitro, treatment with CCM@Ch-Cu/PtNPs (75 µg/mL) markedly decreased viability and colony formation in AGS and HGC gastric cancer cell lines, induced apoptosis, and triggered reactive oxygen species (ROS) generation, indicating potent cytotoxic activity and disruption of oncogenic pathways. In vivo, systemic administration of CCM@Ch-Cu/PtNPs in a murine gastric cancer model resulted in preferential tumor accumulation, substantial tumor growth inhibition, and prolonged survival, all achieved without detectable organ toxicity. These results support the potential of CCM@Ch-Cu/PtNPs as a theranostic nanomedicine platform for targeted gastric cancer therapy.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13326463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147863975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural diversity-guided catalytic-core chimerism engineers a rapid and inhibitor-tolerant reverse transcriptase. 自然多样性引导催化核心嵌合工程快速和耐抑制剂逆转录酶。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-05-07 DOI: 10.1186/s13036-026-00692-3
Inês Fonseca Costa, Vânia Ondina Fernandes, Rita Silva Simões, Hélvio Simões, Virgínia Maria Rico Pires, Victor Diogo Alves, João Soeiro Teodoro, Pedro Bule, Carlos Mendes Godinho de Andrade Fontes
{"title":"Natural diversity-guided catalytic-core chimerism engineers a rapid and inhibitor-tolerant reverse transcriptase.","authors":"Inês Fonseca Costa, Vânia Ondina Fernandes, Rita Silva Simões, Hélvio Simões, Virgínia Maria Rico Pires, Victor Diogo Alves, João Soeiro Teodoro, Pedro Bule, Carlos Mendes Godinho de Andrade Fontes","doi":"10.1186/s13036-026-00692-3","DOIUrl":"10.1186/s13036-026-00692-3","url":null,"abstract":"<p><strong>Background: </strong>Reverse transcriptases (RTs) are essential components of RNA-based molecular technologies, yet their practical performance is often constrained by trade-offs between catalytic speed, thermal stability, and tolerance to inhibitory substances. Conventional optimization via mutagenesis or directed evolution often improves individual traits but struggles to integrate multiple traits within a single enzyme. Here, we applied catalytic-core recombination, guided by natural sequence diversity and diagnostic performance criteria, to recover reverse transcriptase phenotypes that would be difficult to obtain by single-trait optimization alone.</p><p><strong>Results: </strong>Starting from 1,028 sequences, 24 representative RT variants were used to generate a library of chimeras by swapping a critical 405-residue polymerase domain into a validated M-MuLV scaffold. We identified chRT V18 as the lead candidate, demonstrating consistent activity across a broad temperature range (40-70 °C). In addition, chRT V18 enabled efficient and linear cDNA synthesis in as little as 1 min at elevated temperatures, while maintaining strong resistance to clinically relevant inhibitors. Beyond RT-qPCR, chRT V18 supported high-temperature RT-LAMP at 69 °C, a regime typically incompatible with conventional RTs, enabling improved specificity and rapid amplification. When formulated into one-step RT-qPCR master mixes, chRT V18 achieved low limits of detection and full concordance with IVD-approved assays, while reducing reverse transcription time by 90%, enabling shorter time-to-result.</p><p><strong>Conclusions: </strong>Natural diversity-guided catalytic-core chimerism enabled the development of a rapid, inhibitor-tolerant reverse transcriptase with an unusual combination of broad temperature compatibility, minute-scale reverse transcription, and resilience to clinically relevant inhibitors. Beyond the properties of chRT V18 itself, the results support modular recombination of evolutionarily optimized domains as a practical engineering strategy for integrating multiple performance traits in complex enzymes.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13317365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147838437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proof-of-concept engineering of Escherichia coli expressing a bee-derived cytochrome P450 monooxygenase for thiamethoxam detoxification. 表达蜜蜂来源的细胞色素P450单加氧酶的大肠杆菌的概念工程证明,用于噻虫嗪解毒。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-05-07 DOI: 10.1186/s13036-026-00686-1
Pachara Sattayawat, Kasimaporn Promubon, Kritapas Sripinta, Warisa Chunguaongsuk, Chonlaphon Juntama, Nuttapol Noirungsee, Aussara Panya, Terd Disayathanoowat
{"title":"Proof-of-concept engineering of Escherichia coli expressing a bee-derived cytochrome P450 monooxygenase for thiamethoxam detoxification.","authors":"Pachara Sattayawat, Kasimaporn Promubon, Kritapas Sripinta, Warisa Chunguaongsuk, Chonlaphon Juntama, Nuttapol Noirungsee, Aussara Panya, Terd Disayathanoowat","doi":"10.1186/s13036-026-00686-1","DOIUrl":"10.1186/s13036-026-00686-1","url":null,"abstract":"<p><p>Bees are unintentionally exposed to pesticides applied to control other insect pests. Although bees possess endogenous detoxification mechanisms, their efficiency may not always be sufficient. To this end, the use of probiotics that can assist in pesticide detoxification may offer an additional layer of protection. In this study, we engineered Escherichia coli BL21(DE3) to heterologously express the bee-derived cytochrome P450 monooxygenase (CYP450), CYP9Q1, from Apis mellifera as a proof-of-concept microbial platform for thiamethoxam biotransformation and future microbiome-assisted pesticide detoxification strategies. We first assessed the toxicity of thiamethoxam, a systemic insecticide, on E. coli, which showed obvious impaired growth at relatively high concentrations (5 and 10 g/L). Subsequently, we computationally modeled the 3D structure and modified the CYP450 to improve its solubility when expressed in E. coli. Molecular docking of the CYP450 and thiamethoxam was also performed to confirm their potential interaction. pRSFDuet-1 plasmid was used to carry the modified CYP450 gene for expression in E. coli and the induction condition was optimized, with 0.5 mM isopropyl 𝛽-D-1-thiogalactopyranoside (IPTG) yielding the most favorable expression level. A whole-cell detoxification assay subsequently showed reduced concentrations of thiamethoxam after 46 h of biocatalytic activity, as monitored by High-Performance Liquid Chromatography (HPLC). Liquid Chromatography-Mass Spectrometry (LC-MS) analysis further revealed the presence of desnitro thiamethoxam corresponding to m/z 247.04105 confirming enzymatic transformation of thiamethoxam. To our knowledge, this study provides the first demonstration of bee CYP9Q1 heterologous expression in E. coli for whole-cell thiamethoxam biotransformation, highlighting its potential as a platform for developing probiotic or gut microbiome-based detoxification strategies to support bee pesticide tolerance.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13321449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147838390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early bioprocess development using Komagataella phaffii: application scenarios for the microTOM mini bioreactor system. 利用法菲Komagataella的早期生物工艺开发:microTOM微型生物反应器系统的应用场景。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-05-06 DOI: 10.1186/s13036-026-00691-4
David Wollborn, Carol J Hartley, Andreas Schulte, Juan C P Correa
{"title":"Early bioprocess development using Komagataella phaffii: application scenarios for the microTOM mini bioreactor system.","authors":"David Wollborn, Carol J Hartley, Andreas Schulte, Juan C P Correa","doi":"10.1186/s13036-026-00691-4","DOIUrl":"10.1186/s13036-026-00691-4","url":null,"abstract":"<p><p>Developing novel bioprocesses usually starts with an iterative cycle to engineer genetically modified organisms. This leads to large strain libraries that differ in their genetic makeup, showing different growth and production performance. Finding the optimal production strain requires extensive screening and is arguably one of the most important steps for large-scale productivity. For aerobic processes, it is important to ensure the cultivation conditions avoid oxygen limitation. The oxygen transfer rate (OTR) is a parameter to monitor metabolic activity. The micro-scale Transfer rate Online Measurement (microTOM) system allows online monitoring of the respiration activity in 96-individual wells of a microtiter plate. This novel late-stage beta version prototype, provided by Kuhner Shaker, was trialled with the common microbial host Komagataella phaffii. It is demonstrated how the microTOM system can be applied to rapidly determine essential parameters for bioprocess design. Using a 96-well microtiter plate format enabled high-throughput investigation of three strains in parallel. The methanol uptake and growth rate was estimated, which can be used in process models to guide scale-up and decisions regarding feeding rates in fed-batch operation mode. Further, we assessed seven media formulations with two carbon sources, the impact of filling volume on the maximum oxygen transfer capacity, eight different antifoam agents, and growth rates were estimated at five different temperatures. These findings can help select screening conditions and demonstrate how the microTOM system can accelerate bioprocess development. Until now, obtaining high-resolution OTR datasets at high-throughput, suitable for deriving critical process parameters, has not been feasible. Thus, the microTOM supports robust, data-driven bioprocess development.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13317299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147838301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanical isolation of stromal vascular fraction using a spiral-based device: cellular outcomes and point-of-care workflow considerations. 使用螺旋装置机械分离基质血管部分:细胞结果和护理点工作流程考虑。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-05-06 DOI: 10.1186/s13036-026-00688-z
Marcos Sforza, Olga Ivanenko, Nazanin Biabani, Lara Sforza, Deepak M Kalaskar, Zahra Mohri, Afshin Mosahebi
{"title":"Mechanical isolation of stromal vascular fraction using a spiral-based device: cellular outcomes and point-of-care workflow considerations.","authors":"Marcos Sforza, Olga Ivanenko, Nazanin Biabani, Lara Sforza, Deepak M Kalaskar, Zahra Mohri, Afshin Mosahebi","doi":"10.1186/s13036-026-00688-z","DOIUrl":"10.1186/s13036-026-00688-z","url":null,"abstract":"<p><strong>Background: </strong>Stromal vascular fraction (SVF) from adipose tissue represents a promising source of regenerative cells. A major trend in SVF isolation is the increasing use of dedicated devices and systems to enhance standardization and reproducibility. Real-world implementation of new technologies requires consideration of workflow-related factors alongside biological results. This study primarily aimed to characterize the novel BMC Uniq® SVF device, describe a mechanical isolation approach (MI-SVF) with this device, and evaluate the cellular outcomes of MI-SVF. Enzymatic isolation (EI-SVF) was included as a reference method for comparison of selected cellular parameters.</p><p><strong>Results: </strong>The BMC Uniq® SVF device is a spiral-based, closed system composed of two housings and three filters, designed as a sterile disposable unit. Lipoaspirate samples from 10 healthy female donors were equally divided and handled using MI-SVF (decantation, device processing, centrifugation) or EI-SVF (adding collagenase and post-digestion steps to the MI-SVF protocol). Total cell yield was significantly greater in the EI-SVF group (mean ± standard error (SE) 94.9 × 10<sup>4</sup> ± 6.4 × 10<sup>4</sup> versus 37.5 × 10<sup>4</sup> ± 2.7 × 10<sup>4</sup> for MI-SVF; p = 0.002). The flow cytometry demonstrated significantly higher relative proportions of CD90+ (10.3 ± 1.3% versus 5.4 ± 0.9%; p = 0.014) and CD73+ cells (10.7 ± 0.7% versus 6.6 ± 0.7%; p = 0.010) in MI-SVF compared with EI-SVF, with no significant differences in CD105+ percentage. There were no differences in cell viability (MI-SVF: mean 87.0%; EI-SVF: 83.9%). MI-SVF samples showed a CFU-F frequency of 5.0 ± 0.3% and consistently demonstrated adipogenic, chondrogenic, and osteogenic differentiation potential.</p><p><strong>Conclusions: </strong>The BMC Uniq® SVF device is a simple closed single-use system for mechanical SVF extraction in point-of-care applications. Fresh MI-SVF samples derived in such a way had one of the highest reported cell yields and demonstrated viability, immunophenotype, clonogenic capacity, and multilineage differentiation potential that were comparable to, and in some cases exceeded, those of previously described non-enzymatic protocols. Relative to EI-SVF, the mechanical approach showed a lower total cell count but a higher relative percentage of CD73+ and CD90+ cells. In general, this work contributes to a broader framework for assessing SVF isolation methods by integrating biological performance with practical aspects of clinical workflow.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13312744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147838363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles combined with injectable hydrogels in bone defect repair: a systematic review and meta-analysis of preclinical studies. 间充质干细胞来源的细胞外囊泡联合可注射水凝胶在骨缺损修复中的疗效:临床前研究的系统回顾和荟萃分析。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-04-29 DOI: 10.1186/s13036-026-00684-3
Amir Hossein Aghayan, Davood Mohammadi, Hamed Soleimani Samarkhazan, Amir Atashi, Zahra Jamalpoor
{"title":"Therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles combined with injectable hydrogels in bone defect repair: a systematic review and meta-analysis of preclinical studies.","authors":"Amir Hossein Aghayan, Davood Mohammadi, Hamed Soleimani Samarkhazan, Amir Atashi, Zahra Jamalpoor","doi":"10.1186/s13036-026-00684-3","DOIUrl":"10.1186/s13036-026-00684-3","url":null,"abstract":"<p><p>BACKGROUND: Critical-sized bone defects represent a major clinical challenge due to their limited intrinsic regenerative potential and the considerable limitations of existing surgical interventions. In recent years, the integration of mesenchymal stem cell-derived extracellular vesicles (MSCEVs) with injectable hydrogels (IHs) has gained attention as a promising, cell-free regenerative approach. Although each component independently confers therapeutic benefits, their combined efficacy has not yet been thoroughly evaluated. METHODS: This systematic review and meta-analysis was conducted in accordance with PRISMA 2020 guidelines. Relevant studies were identified through comprehensive searches in PubMed, Embase, Scopus, Web of Science, and ProQuest. Standardized mean differences (SMD) were calculated using a random-effects model. Risk of bias was assessed using the SYRCLE tool, and sensitivity analysis, publication bias assessment, and subgroup analyses were conducted. RESULTS: A quantitative analysis of the included literature revealed that MSCEV-IHs constructs significantly enhanced bone regeneration compared with the control groups, with improved BV/TV at 4 weeks (SMD = 3.52) and 8 weeks (SMD = 6.30), BMD (SMD = 5.45), trabecular number (SMD = 7.52), and thickness (SMD = 6.46). Angiogenesis (SMD = 3.53) and osteogenic markers RUNX2 (SMD = 5.86), BMP2 (SMD = 2.57), OPN (SMD = 7.22), and OCN (SMD = 7.66) were significantly upregulated. CONCLUSION: The use of MSCEVs in combination with IHs has demonstrated substantial potential to enhance both angiogenesis and osteogenic activity in bone defects. However, the considerable heterogeneity across existing studies presents a major barrier to clinical translation. To advance this strategy toward clinical application, harmonized protocols and standardized methodologies are critically needed for consistent validation and optimization. </p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13267703/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147771901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends of nucleic acid - based point-of-care diagnostics for infectious diseases. 基于核酸的传染病即时诊断的发展趋势。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-04-29 DOI: 10.1186/s13036-026-00681-6
Hossam Hatem, Mohamed Mysara, Raghda Ramadan
{"title":"Trends of nucleic acid - based point-of-care diagnostics for infectious diseases.","authors":"Hossam Hatem, Mohamed Mysara, Raghda Ramadan","doi":"10.1186/s13036-026-00681-6","DOIUrl":"10.1186/s13036-026-00681-6","url":null,"abstract":"<p><p>The global emergence and spread of infectious diseases highlights the importance of having an easily accessible, decentralized testing modality that is adept at quickly identifying the nucleic acids present in a Point-of-Care (PoC) setting. PoC-based nucleic acid diagnostics encompass a broad range of platforms, such as lateral flow, biochips, and biosensors, whose primary goal has always been to offer sensitive, selective, and economically viable testing beyond conventional laboratory facilities. The current review illustrates a comprehensive overview of PoC-based nucleic acid diagnostics for infectious diseases, as it is divided into three major operational steps: nucleic acid extraction, amplification, and detection. Firstly, it describes strategies that could effectively work as a PoC, such as magnetic bead-based, paper-based, and integrated microfluidic approaches, while further focusing on their ability to remain simplified, rugged, and equipment-free. Secondly, it summarizes key amplification methods, such as Polymerase Chain Reaction (PCR), Nucleic Acid Sequence-Based Amplification (NASBA), Recombinase Polymerase Amplification (RPA), and Loop-Mediated Isothermal Amplification (LAMP), as they have all been modified to effectively work under more rapid, low-power, and portable conditions. Lastly, it introduces all presently known detection platforms, starting from simpler colorimetric and fluorescent assays present in lateral flow or device platforms, to innovative and advanced biosensors like those exploiting CRISPR/Cas systems and toehold switch principles, as these detectively offer highly sensitive and highly programmable nucleic acid recognition.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13130695/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147771882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic rewiring for enhanced itaconate yield through heterotrophic CO2 fixation in Escherichia coli. 通过异养型二氧化碳固定在大肠杆菌中提高衣康酸产量的代谢重组。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-04-28 DOI: 10.1186/s13036-026-00687-0
Dae-Yeol Ye, Myeongwon Min, Ga Yeon Lim, Hyun Gyu Hwang, Gyoo Yeol Jung, Hyun Gyu Lim
{"title":"Metabolic rewiring for enhanced itaconate yield through heterotrophic CO<sub>2</sub> fixation in Escherichia coli.","authors":"Dae-Yeol Ye, Myeongwon Min, Ga Yeon Lim, Hyun Gyu Hwang, Gyoo Yeol Jung, Hyun Gyu Lim","doi":"10.1186/s13036-026-00687-0","DOIUrl":"10.1186/s13036-026-00687-0","url":null,"abstract":"<p><p>BACKGROUND: It is crucial to obtain high production yields in the microbial production of diverse biochemicals to maximize economic viability. However, microorganisms, particularly heterotrophs, release carbon dioxide (CO2) during the oxidation of organic compounds for energy and building blocks. This metabolism limits the theoretical maximum carbon yield and constrains the development of efficient microbial cell factories. Specifically, metabolite production from tricarboxylic acid (TCA)-cycle intermediates involves major CO2 emission steps, leading to unavoidable carbon loss. RESULTS: Central carbon metabolism in Escherichia coli, a model heterotroph, was synthetically rewired to facilitate CO2 fixation and escalate carbon yields. Specifically, we blocked multiple routes to prevent pyruvate oxidation to acetyl-CoA, which was identified as a major CO2 emission step, and promoted CO2 incorporation into TCA cycle intermediates by reengineering endogenous pathways for co-utilization of glucose and acetate. This strategy was applied to produce itaconate, a promising bioplastic precursor, achieving a yield of 0.81 C mol/C substrate mol, a value near the theoretical maximum yield obtainable from glucose (0.83 C mol/C mol). CONCLUSIONS: This heterotrophic CO2 fixation strategy can be used to produce TCA-derived chemicals and enhance the economic viability of microbial production. This study demonstrates that synthetically rewiring central carbon metabolism enables direct incorporation of CO₂ into the product, thereby increasing carbon yields approaching the conventional maximum value. This heterotrophic CO2 fixation strategy not only provides a breakthrough for efficient itaconate production but also serves as a versatile platform for engineering microbial cell factories to produce various TCA-derived chemicals with amplified carbon yield. </p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13262084/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147771923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书